A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, ...

In a joint report published on Monday, analysts estimated the market for obesity treatments could expand to $200 billion by ...

Market leaders Wegovy from Novo Nordisk and Zepbound from Eli Lilly are both injectable drugs. The two companies are also ...

The experimental treatment, TERN-601, is part of the second generation of weight-loss drugs, which aim to offer a more ...

Here are four big drug/biotech stocks, LLY, RHHBY, NVS and PFE, which you should buy today for lucrative long-term returns.

In the United States and some countries other than Europe, Lilly owns exclusive development and commercialization rights to ...

Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall Street analysts ...

While Congress twiddles its thumbs, pharmaceutical giants like Lilly, Pfizer, and Nova Nordisk are revolutionizing healthcare ...

Pfizer has even done something similar before, rolling out a mail-order option for its cholesterol drug Lipitor at generic prices after its patent expired in 2011. PfizerForAll will provide access ...